Switching on/off amyloid plaque formation in transgenic animal models of Alzheimer's disease

SA Kozin, OI Kechko, AA Adzhubei… - International Journal of …, 2023 - mdpi.com
A hallmark of Alzheimer's disease (AD) are the proteinaceous aggregates formed by the
amyloid-beta peptide (Aβ) that is deposited inside the brain as amyloid plaques. The …

Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer's Disease: A Recent Systematic Review

C Munteanu, DA Iordan, M Hoteteu, C Popescu… - International Journal of …, 2023 - mdpi.com
In the rapidly evolving field of Alzheimer's Disease (AD) research, the intricate role of
Hydrogen Sulfide (H2S) has garnered critical attention for its diverse involvement in both …

Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime …

V Volloch, S Rits-Volloch - International Journal of Molecular Sciences, 2023 - mdpi.com
Although the long-standing Amyloid Cascade Hypothesis (ACH) has been largely
discredited, its main attribute, the centrality of amyloid-beta (Aβ) in Alzheimer's disease (AD) …

On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward

V Volloch, S Rits-Volloch - International Journal of Molecular Sciences, 2024 - mdpi.com
For at least two reasons, the current transgenic animal models of Alzheimer's disease (AD)
appear to be patently inadequate. They may be useful in many respects, the AD models; …

Neurodegenerative Disease: From Molecular Basis to Therapy

C Ricci - International Journal of Molecular Sciences, 2024 - mdpi.com
Neurodegenerative diseases are a heterogeneous group of age-related disorders
characterised by the progressive degeneration or death of neurons in the central or …

Potential molecular pathways of angiotensin receptor blockers in the brain toward cognitive improvement in dementia

V Karmakar, B Gorain - Drug Discovery Today, 2023 - Elsevier
The alarming rise of cognitive impairment and memory decline and limited effective
solutions present a worldwide concern for dementia patients. The multivariant role of the …

Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer's Disease and Aging-Associated Cognitive Decline in the ACH2. 0 Perspective …

V Volloch, S Rits-Volloch - Journal of Alzheimer's Disease …, 2023 - content.iospress.com
Abstract With the Amyloid Cascade Hypothesis (ACH) largely discredited, the ACH2. 0
theory of Alzheimer's disease (AD) has been recently introduced. AD is triggered by amyloid …

ACH2. 0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies

V Volloch, S Rits-Volloch - International Journal of Molecular Sciences, 2024 - mdpi.com
The centrality of amyloid-beta (Aβ) is an indisputable tenet of Alzheimer's disease (AD). It
was initially indicated by the detection (1991) of a mutation within Aβ protein precursor …

Reduced Expression of CLEC4G in Neurons Is Associated with Alzheimer's Disease

X Feng, F Qi, Y Huang, G Zhang, W Deng - International Journal of …, 2024 - mdpi.com
CLEC4G, a glycan-binding receptor, has previously been demonstrated to inhibit Aβ
generation, yet its brain localization and functions in Alzheimer's disease (AD) are not clear …

NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer's disease

B Hu, J Zhang, J Huang, B Luo, X Zeng… - Neural Regeneration …, 2024 - journals.lww.com
The inflammasome is a multiprotein complex involved in innate immunity that mediates the
inflammatory response leading to pyroptosis, which is a lytic, inflammatory form of cell death …